2002
DOI: 10.1104/pp.008573
|View full text |Cite
|
Sign up to set email alerts
|

Comparative Molecular and Functional Analyses of the Tobacco Cyclin-Dependent Kinase Inhibitor NtKIS1a and Its Spliced Variant NtKIS1b

Abstract: In all eukaryotes, cell cycle progression is controlled by cyclin-dependent kinases (CDKs) whose activity is regulated at several levels including inhibition by CDK inhibitors. Here, we report a comparative molecular and functional analysis of the tobacco (Nicotiana tomentosiformis) CDK inhibitor, NtKIS1a, and its spliced variant, NtKIS1b. The C-terminal end of NtKIS1a shares strong sequence similarity with mammalian CIP/KIP inhibitors, which is not the case for NtKIS1b. Consistent with this, NtKIS1a but not N… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
63
0

Year Published

2004
2004
2018
2018

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 48 publications
(67 citation statements)
references
References 38 publications
4
63
0
Order By: Relevance
“…In 35S:AtSulA-GFP plants, transcripts accumulate at very high levels, whereas the AtSulA-GFP protein does not, indicating a translational or posttranslational regulation of the transgene expression. Moreover, we have shown previously that overexpression of the NtKIS cell-cycle inhibitor fused to GFP results in homogeneous GFP staining in all cells throughout plant development (Jasinski et al, 2002). Therefore, the heterogeneity of AtSulA-GFP accumulation between cells does not result from variation of transgene transcription from one cell to another.…”
Section: Discussionmentioning
confidence: 81%
“…In 35S:AtSulA-GFP plants, transcripts accumulate at very high levels, whereas the AtSulA-GFP protein does not, indicating a translational or posttranslational regulation of the transgene expression. Moreover, we have shown previously that overexpression of the NtKIS cell-cycle inhibitor fused to GFP results in homogeneous GFP staining in all cells throughout plant development (Jasinski et al, 2002). Therefore, the heterogeneity of AtSulA-GFP accumulation between cells does not result from variation of transgene transcription from one cell to another.…”
Section: Discussionmentioning
confidence: 81%
“…It should be noted that the proteins were numbered sequentially and, consequently, that the KRP members from rice and other species should not be regarded as systematic orthologs. Sequence similarity between the KRPs of rice and other plants is mostly concentrated in a region of 40 amino acids located at the extreme C-terminal end of each KRP, which encompasses the conserved motifs 1, 2, and 3 of plant ICK/KRPs (De Veylder et al, 2001;Jasinski et al, 2002). Conserved motifs 1 and 2 include the CDKbinding box, whereas motif 3 corresponds to the CYCD-binding box (Wang et al, 1998).…”
Section: Identification Of Rice Krp Genes and Characterization Of Orymentioning
confidence: 99%
“…In tobacco (Nicotiana tabacum), a KRP-like inhibitor designated NtKIS1a was isolated by a yeast two-hybrid screen. Overexpression of this gene in Arabidopsis (Arabidopsis thaliana) reduced CDK kinase activity (Jasinski et al, 2002). Also, the tomato (Lycopersicon esculentum) LeKRP1 has recently been shown to inhibit CDK/CYC kinase activities in endoreduplicating cells of the gel tissue (Bisbis et al, 2006).…”
Section: Kip2mentioning
confidence: 99%
See 1 more Smart Citation
“…Overexpression of KRP1 or KRP2 inhibits cell division and changes morphogenesis of leaves that contain less but larger cells (Wang, et al, 2000;De Veylder, et al, 2001), an effect partially reversed by overexpression of an inducer of cell division, such as CYCD3 (Zhou, et al, 2003). Likewise, overexpression of tobacco CDK inhibitor (KIS1) reverses the altered leaf phenotype of plants expressing CYCD3 ectopically (Jasinski, et al, 2002). This indicates that a proper balance of cell division activity and cell cycle arrest is required to develop a correct morphogenetic pattern.…”
Section: Cdk Inhibitorsmentioning
confidence: 94%